Not provided
Not provided
Not provided
Not provided
Not provided
Early termination due to low enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CardioVascular Research Foundation, Korea | OTHER |
Not provided
Not provided
Not provided
Not provided
This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Multivessel coronary artery disease | must include left anterior descending artery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hybrid Coronary Revascularization | Procedure | Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels. |
| Measure | Description | Time Frame |
|---|---|---|
| a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke. | Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke. | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| All death | 5 years | |
| Cardiac death | 5 years | |
| Myocardial infarction |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asan Medical Center | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D023921 | Coronary Stenosis |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| 5 years |
| a composite event of all death or myocardial infarction | 5 years |
| a composite event of cardiac death or myocardial infarction | 5 years |
| TVR(Target Vessel Revascularization) | 5 years |
| TLR(Target Lesion Revascularization) | 5 years |
| Stent thrombosis | by an Academic Research Consortium (ARC) category | 5 years |
| Cerebrovascular event | 5 years |
| Procedural success | Procedural success is defined as < 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization. | 5 days |
| D014652 |
| Vascular Diseases |